Werfen Gets FDA 510(k) Clearance for ROTEM Sigma Thromboelastometry System
Werfen’s ROTEM sigma Thromboelastometry System received 510(k) clearance by the U.S. Food and Drug Administration.
Read MorePosted by Andy Lundin | Jul 19, 2022 | Hematology & Serology |
Werfen’s ROTEM sigma Thromboelastometry System received 510(k) clearance by the U.S. Food and Drug Administration.
Read MorePosted by Chris Wolski | May 4, 2022 | Immunoassay Reagents & test Kits |
HORIBA Medical announces that its novel hemostatic D-dimer immunoassay, Yumizen G DDi 2, has been independently validated.
Read MorePosted by Andy Lundin | Apr 28, 2022 | Covid 19, Womens Health |
Researchers conducted a study where they questioned the extent to which Preeclampsia and COVID share biological characteristics.
Read MorePosted by Andy Lundin | Jan 5, 2022 | Company News, Diagnostic Technologies, Hematology Instrumentation |
Werfen says its GEM Hemochron 100 Whole Blood Hemostasis system received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Read MorePosted by Melanie Hamilton-Basich | Jul 12, 2021 | Company News |
Werfen’s companies, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, are uniting under one name and one brand: Werfen.
Read More